ArticleJournal of general internal medicine2026
An Observational Study of Post-hip Fracture Outcomes in Older Adults with Type 2 Diabetes.
Article in Journal of general internal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundHip fracture is a global public health concern, with over 10 million cases worldwide in 2019. Post-hip fracture outcomes, including mortality, vary by type 2 diabetes (T2D) co-diagnosis and patient demographics.
objectiveTo examine post-hip fracture outcomes and identify factors modifying mortality differences in a racially and ethnically diverse population of older United States (US) adults with T2D.
designRetrospective cohort study using Medicare fee-for-service data from 2014 to 2020.
participantsMen and women aged > 65 years, with T2D diagnosis who had experienced a non-traumatic hip fracture. MAIN MEASURE(S): We evaluated associations between race and ethnicity and one-year mortality, dual energy x-ray absorptiometry (DXA) testing, osteoporosis treatment, and incident destitution post-hip fracture using multivariable Cox proportional hazards models. KEY
resultsAmong 159,699 older adults with T2D, one-year post-hip fracture mortality was 30.4%. In age- and sex-adjusted models, mortality was higher in Black individuals (HR 1.26 [95% CI, 1.22-1.31) and lower in Asian and Hispanic individuals (HR 0.78 [95% CI, 0.73-0.83] and 0.91 [95% CI,0.86-0.96], respectively) compared with White individuals. Elevated mortality in Black individuals persisted across subgroups stratified by sex, age, region, BMI, and frailty, but not among those with advanced chronic kidney disease (CKD stages 4-5; HR 1.01 [0.93-1.09]) or low socioeconomic status (SES; Medicaid eligibility; HR 1.00 [0.88-1.14]). Models adjusting for important demographic and clinical covariates mitigated mortality differences between Black and White individuals. DXA testing and osteoporosis treatment initiation rates were low overall (7.3% and 5.6%, respectively). Black individuals had lower DXA testing (HR 0.51 [0.45-0.56]) and treatment (HR 0.58 [0.51-0.65]) rates, and higher incident destitution (HR 1.41 [1.29-1.55]) than White individuals in all models.
conclusionsOverall mortality was high and guideline-concordant care was low in the first year post-hip fracture in Medicare-insured older adults with T2D. Furthermore, racial and ethnic differences in post-hip fracture mortality and management exist.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.